Cargando…
Electroporation as the Immunotherapy Strategy for Cancer in Veterinary Medicine: State of the Art in Latin America
Electroporation is a technology that increases cell membrane permeability by the application of electric pulses. Electrochemotherapy (ECT), the best-known application of electroporation, is a very effective local treatment for tumors of any histology in human and veterinary medicine. It induces a lo...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564659/ https://www.ncbi.nlm.nih.gov/pubmed/32957424 http://dx.doi.org/10.3390/vaccines8030537 |
_version_ | 1783595765572042752 |
---|---|
author | Maglietti, Felipe Tellado, Matías De Robertis, Mariangela Michinski, Sebastián Fernández, Juan Signori, Emanuela Marshall, Guillermo |
author_facet | Maglietti, Felipe Tellado, Matías De Robertis, Mariangela Michinski, Sebastián Fernández, Juan Signori, Emanuela Marshall, Guillermo |
author_sort | Maglietti, Felipe |
collection | PubMed |
description | Electroporation is a technology that increases cell membrane permeability by the application of electric pulses. Electrochemotherapy (ECT), the best-known application of electroporation, is a very effective local treatment for tumors of any histology in human and veterinary medicine. It induces a local yet robust immune response that is responsible for its high effectiveness. Gene electrotransfer (GET), used in research to produce a systemic immune response against cancer, is another electroporation-based treatment that is very appealing for its effectiveness, low cost, and simplicity. In this review, we present the immune effect of electroporation-based treatments and analyze the results of the vast majority of the published papers related to immune response enhancement by gene electrotransfer in companion animals with spontaneous tumors. In addition, we present a brief history of the initial steps and the state of the art of the electroporation-based treatments in Latin America. They have the potential to become an essential form of immunotherapy in the region. This review gives insight into the subject and helps to choose promising research lines for future work; it also helps to select the adequate treatment parameters for performing a successful application of this technology. |
format | Online Article Text |
id | pubmed-7564659 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-75646592020-10-29 Electroporation as the Immunotherapy Strategy for Cancer in Veterinary Medicine: State of the Art in Latin America Maglietti, Felipe Tellado, Matías De Robertis, Mariangela Michinski, Sebastián Fernández, Juan Signori, Emanuela Marshall, Guillermo Vaccines (Basel) Review Electroporation is a technology that increases cell membrane permeability by the application of electric pulses. Electrochemotherapy (ECT), the best-known application of electroporation, is a very effective local treatment for tumors of any histology in human and veterinary medicine. It induces a local yet robust immune response that is responsible for its high effectiveness. Gene electrotransfer (GET), used in research to produce a systemic immune response against cancer, is another electroporation-based treatment that is very appealing for its effectiveness, low cost, and simplicity. In this review, we present the immune effect of electroporation-based treatments and analyze the results of the vast majority of the published papers related to immune response enhancement by gene electrotransfer in companion animals with spontaneous tumors. In addition, we present a brief history of the initial steps and the state of the art of the electroporation-based treatments in Latin America. They have the potential to become an essential form of immunotherapy in the region. This review gives insight into the subject and helps to choose promising research lines for future work; it also helps to select the adequate treatment parameters for performing a successful application of this technology. MDPI 2020-09-17 /pmc/articles/PMC7564659/ /pubmed/32957424 http://dx.doi.org/10.3390/vaccines8030537 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Maglietti, Felipe Tellado, Matías De Robertis, Mariangela Michinski, Sebastián Fernández, Juan Signori, Emanuela Marshall, Guillermo Electroporation as the Immunotherapy Strategy for Cancer in Veterinary Medicine: State of the Art in Latin America |
title | Electroporation as the Immunotherapy Strategy for Cancer in Veterinary Medicine: State of the Art in Latin America |
title_full | Electroporation as the Immunotherapy Strategy for Cancer in Veterinary Medicine: State of the Art in Latin America |
title_fullStr | Electroporation as the Immunotherapy Strategy for Cancer in Veterinary Medicine: State of the Art in Latin America |
title_full_unstemmed | Electroporation as the Immunotherapy Strategy for Cancer in Veterinary Medicine: State of the Art in Latin America |
title_short | Electroporation as the Immunotherapy Strategy for Cancer in Veterinary Medicine: State of the Art in Latin America |
title_sort | electroporation as the immunotherapy strategy for cancer in veterinary medicine: state of the art in latin america |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564659/ https://www.ncbi.nlm.nih.gov/pubmed/32957424 http://dx.doi.org/10.3390/vaccines8030537 |
work_keys_str_mv | AT magliettifelipe electroporationastheimmunotherapystrategyforcancerinveterinarymedicinestateoftheartinlatinamerica AT telladomatias electroporationastheimmunotherapystrategyforcancerinveterinarymedicinestateoftheartinlatinamerica AT derobertismariangela electroporationastheimmunotherapystrategyforcancerinveterinarymedicinestateoftheartinlatinamerica AT michinskisebastian electroporationastheimmunotherapystrategyforcancerinveterinarymedicinestateoftheartinlatinamerica AT fernandezjuan electroporationastheimmunotherapystrategyforcancerinveterinarymedicinestateoftheartinlatinamerica AT signoriemanuela electroporationastheimmunotherapystrategyforcancerinveterinarymedicinestateoftheartinlatinamerica AT marshallguillermo electroporationastheimmunotherapystrategyforcancerinveterinarymedicinestateoftheartinlatinamerica |